In the passing weak, market participants were expecting that the government might get clearance on the GST and bankruptcy bill in the winter session of the parliament but the same could not happen and the current year’s last important event couldn’t yield any result.
At present, stock selection is the key. Traders can concentrate at Pharma and Consumption sectors for taking fresh positions. While on the sell side PSU Bank and Realty can be considered.
It will be wise to buy quality pharma stocks like AUROPHARMA, DIVISLAB for medium to long-term prospective.
On the stock-specific front, one can concentrate at MARUTI, MARICO, HINDUNILVR, ASIANPAINT form this space for short-term trading as well as investment.